Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06656702 · ClinicalTrials.gov registry record · Early Phase 1

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

A Early Phase 1 study of Amyotrophic Lateral Sclerosis, sponsored by Johns Hopkins University.

Recruiting
Registry status
Early Phase 1
Development phase
24
Enrollment target
1
Study location

NCT06656702 is a Early Phase 1 study of Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 24 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06656702, a Early Phase 1 study of Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Early Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study aims to study the feasibility of psilocybin therapy for patients with Amyotropic Lateral Sclerosis (ALS) with depressed mood. The secondary objective is to assess its impact on depression, quality of life, hopelessness, and functional status in this patient population.

Conditions Studied

Amyotrophic Lateral Sclerosis

Interventions

  • DRUG Psilocybin

Study Locations (1)

Maryland

  • Johns Hopkins Center for Psychedelic and Consciousness Research - Baltimore

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-04-09
Est. Completion 2027-07-01
Phase Early Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06656702

The ClinicalTrials.gov registry entry for NCT06656702 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.

NCT06656702 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06656702 about?

NCT06656702 is a clinical study titled "Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis". This study aims to study the feasibility of psilocybin therapy for patients with Amyotropic Lateral Sclerosis (ALS) with depressed mood. The secondary objective is to assess its impact on depression, quality of life, hopelessness, and functional status in this patient population.

What is the current status of trial NCT06656702?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2025-04-09. Estimated completion is 2027-07-01.

What conditions does trial NCT06656702 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

What interventions are being tested in trial NCT06656702?

The interventions under investigation include: Psilocybin (DRUG).

Who is sponsoring clinical trial NCT06656702?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06656702 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amyotrophic Lateral Sclerosis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.